ATE347106T1 - Diagnose von karzinomen mit hilfe des raig1- polypeptids - Google Patents
Diagnose von karzinomen mit hilfe des raig1- polypeptidsInfo
- Publication number
- ATE347106T1 ATE347106T1 AT03717443T AT03717443T ATE347106T1 AT E347106 T1 ATE347106 T1 AT E347106T1 AT 03717443 T AT03717443 T AT 03717443T AT 03717443 T AT03717443 T AT 03717443T AT E347106 T1 ATE347106 T1 AT E347106T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- cancer
- carcinoma
- diagnosis
- expression
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 101001100101 Homo sapiens Retinoic acid-induced protein 3 Proteins 0.000 title abstract 3
- 102100038453 Retinoic acid-induced protein 3 Human genes 0.000 title abstract 3
- 201000009030 Carcinoma Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 206010033128 Ovarian cancer Diseases 0.000 abstract 1
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 201000008968 osteosarcoma Diseases 0.000 abstract 1
- 201000002528 pancreatic cancer Diseases 0.000 abstract 1
- 208000008443 pancreatic carcinoma Diseases 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0208331A GB0208331D0 (en) | 2002-04-11 | 2002-04-11 | Proteins |
| GB0221538A GB0221538D0 (en) | 2002-09-17 | 2002-09-17 | A protein involved in carcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE347106T1 true ATE347106T1 (de) | 2006-12-15 |
Family
ID=29252443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03717443T ATE347106T1 (de) | 2002-04-11 | 2003-04-10 | Diagnose von karzinomen mit hilfe des raig1- polypeptids |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20050282165A1 (enExample) |
| EP (1) | EP1497656B1 (enExample) |
| JP (2) | JP2005522226A (enExample) |
| AT (1) | ATE347106T1 (enExample) |
| AU (1) | AU2003222606A1 (enExample) |
| DE (1) | DE60310059T2 (enExample) |
| ES (1) | ES2274220T3 (enExample) |
| WO (1) | WO2003087832A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040121362A1 (en) * | 2002-06-20 | 2004-06-24 | Whitney Gena S. | Identification and modulation of a G-protein coupled receptor (GPCR), RAI-3, associated with chronic obstructive pulmonary disease (COPD) and NF-kappaB and E-selectin regulation |
| WO2021045224A1 (ja) * | 2019-09-04 | 2021-03-11 | 国立大学法人東海国立大学機構 | がん免疫療法等における免疫関連有害事象の予測 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030068618A1 (en) * | 2000-07-26 | 2003-04-10 | Muralidharu Padigaru | Novel proteins and nucleic acids encoding same |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| AU2002253878A1 (en) * | 2001-01-25 | 2002-08-06 | Gene Logic, Inc. | Gene expression profiles in breast tissue |
| AU2002324451A1 (en) * | 2001-06-21 | 2003-01-08 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
-
2003
- 2003-04-10 EP EP03717443A patent/EP1497656B1/en not_active Expired - Lifetime
- 2003-04-10 DE DE60310059T patent/DE60310059T2/de not_active Expired - Lifetime
- 2003-04-10 US US10/510,507 patent/US20050282165A1/en not_active Abandoned
- 2003-04-10 WO PCT/GB2003/001587 patent/WO2003087832A2/en not_active Ceased
- 2003-04-10 AT AT03717443T patent/ATE347106T1/de not_active IP Right Cessation
- 2003-04-10 ES ES03717443T patent/ES2274220T3/es not_active Expired - Lifetime
- 2003-04-10 AU AU2003222606A patent/AU2003222606A1/en not_active Abandoned
- 2003-04-10 JP JP2003584724A patent/JP2005522226A/ja active Pending
-
2007
- 2007-11-26 US US11/986,786 patent/US20090258019A1/en not_active Abandoned
-
2009
- 2009-12-16 JP JP2009284846A patent/JP2010117358A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090258019A1 (en) | 2009-10-15 |
| DE60310059T2 (de) | 2007-05-10 |
| ES2274220T3 (es) | 2007-05-16 |
| JP2005522226A (ja) | 2005-07-28 |
| EP1497656B1 (en) | 2006-11-29 |
| WO2003087832A2 (en) | 2003-10-23 |
| AU2003222606A8 (en) | 2003-10-27 |
| WO2003087832A3 (en) | 2004-02-12 |
| JP2010117358A (ja) | 2010-05-27 |
| EP1497656A2 (en) | 2005-01-19 |
| DE60310059D1 (de) | 2007-01-11 |
| US20050282165A1 (en) | 2005-12-22 |
| AU2003222606A1 (en) | 2003-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1124846A4 (en) | NOGO GENE NUCLEOTIDE AND PROTEIN SEQUENCES AND METHODS BASED ON SUCH SEQUENCES | |
| BR0315666A (pt) | Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos | |
| DK0981618T3 (da) | Anti-Apo-2-antistof | |
| DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
| ATE302278T1 (de) | Diagnose und behandlung von aur1 und/oder aur2 verwandten erkrankungen | |
| EA200600525A1 (ru) | Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения | |
| ATE519847T1 (de) | Il-17-homologe polypeptide und ihre therapeutische verwendung | |
| ATE386117T1 (de) | Prostattumor polynukleotid- und antigenzusammensetzungen | |
| AU4929701A (en) | Whole-body optical imaging of gene expression and uses thereof | |
| DE60121346D1 (en) | Suppressor-gen | |
| ATE135371T1 (de) | Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis | |
| ATE302274T1 (de) | Methoden zur bestimmung von komponenten zur modulation des körpergewichts | |
| WO2001064877A3 (en) | Human schizophrenia gene | |
| WO2004019893A3 (en) | Modulators of angiogenesis | |
| DE602004027647D1 (de) | An ovarialkrebs beteiligtes protein | |
| EA200501197A1 (ru) | Композиции и способы для лечения злокачественной опухоли с применением igsf9 и liv - 1 | |
| ATA192799A (de) | Neue verwendung von antikörpern als impfstoffe | |
| ATE347106T1 (de) | Diagnose von karzinomen mit hilfe des raig1- polypeptids | |
| EA200501711A1 (ru) | Семейство секретируемых белков | |
| WO2003087840A3 (en) | Protein involved in cancer | |
| TR200102655T2 (tr) | Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen. | |
| WO2002092765A3 (en) | Novel telomerase inhibitors and uses therefor | |
| ATE306668T1 (de) | Diagnose von brustkrebs unter verwendung von bcmp-7 als marker | |
| EA200700951A1 (ru) | БЕЛКИ, СОДЕРЖАЩИЕ ДОМЕНЫ vWFA И/ИЛИ ANT_IG | |
| WO1999063094A3 (en) | Nucleotide and protein sequences of gpr1 and methods based thereon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |